Nestin Protein expressed in Brain Tumors, Peptide Aptamer, unlabeled

Stock availability

Available
Category

Custom Service
Antibody type

N/A
Antibody host

N/A
Antibody conjugate

N/A
Technical datasheet

Contact Gentaur to request the datasheet or ask our specialists for more information.
Notes

The Nestin Protein expressed in Brain Tumors, Peptide Aptamer, unlabeled is manufactured for Research Use Only or for diagnostics purposes.
Other related products
Description

Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.

Gene target

Nestin Protein expressed Brain Tumors Peptide Aptamer unlabeled
Short name

Nestin Protein expressed in Brain Tumors, Peptide Aptamer, unlabeled
Technique

peptide, peptides
Species

N/A
Alternative name

Nestin Protein expressed in Brain Tumors, short protein sequence Aptamer, unlabeled
Alternative technique

peptides
Tissue

brain

Name

Tumor Stem Cell Assay
Concept

Scope note: A cytologic technique for measuring the functional capacity of tumor stem cells by assaying their activity. It is used primarily for the in vitro testing of antineoplastic agents.
Tree numbers
- E01.370.225.500.383.910
- E01.370.225.500.388.930
- E05.200.500.383.910
- E05.200.500.388.930
- E05.242.383.910
- E05.242.417.500
- E05.337.550.200.800
Qualifiers

ethics, trends, veterinary, history, classification, economics, instrumentation, methods, standards, statistics & numerical data